Fig. 6.
Detection and validation of a private somatic intronic deletion of ITPKB in a lymphoma patient. (A) Detection of a somatic intronic 59-nt deletion of ITPKB that removed all three BP sites in intron-3. (B) RNA-seq reads alignment on ITPKB that showed intronic retention in the lymphoma patient carrying this variant but not in the patients without this variant. (C) Sashimi plot from the RNA-seq data.